Company Korean Drug Co., Ltd.

A014570

KR7014570006

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sector Generic Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
6,050 ^KRW	-0.17%		+1.17%	-15.74%

2023	Korean Drug Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2021	Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 14, 2020.	CI

KOREAN DRUG CO.,LTD is a Korea-based company engaged in the manufacture and distribution of pharmaceuticals. The Companyâs products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.

Number of employees: 270

KRW in Million	2022	Weight	2023	Weight	Delta
Medicine and Pharmaceutical Research and Development 100.0 %	79,984	100.0 %	81,375	100.0 %	+1.74%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	79,984	100.0 %	81,375	100.0 %	+1.74%

Managers	Title	Age	Since
Sang-Hoon Park CEO	Chief Executive Officer	58	-
Hae-Ryong Park CEO	Chief Executive Officer	88	-
Kyung-Deuk Lee BRD	Director/Board Member	62	-
Seung-Gwon Baek PRN	Corporate Officer/Principal	62	-
Gi-Pyeong Lee PRN	Corporate Officer/Principal	66	-
Nam-Gyu Kang AUD	Comptroller/Controller/Auditor	77	-
Hui-Cheon Tak PRN	Corporate Officer/Principal	62	-

Members of the board	Title	Age	Since
Hae-Ryong Park CEO	Chief Executive Officer	88	-
Sang-Hoon Park CEO	Chief Executive Officer	58	-
Kyung-Deuk Lee BRD	Director/Board Member	62	-
Won-Sik Yoon BRD	Director/Board Member	65	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	11,000,000	5,265,374 ( 47.87 %)	211,165 ( 1.920 %)	47.87 %

Name	Equities	%	Valuation
Sang-Hoon Park 38.85 %	4,273,330	38.85 %	19 M ₩
Hae-Ryong Park 10.00 %	1,100,000	10.00 %	5 M ₩
KOREAN DRUG CO., LTD. 1.954 %	214,911	1.954 %	962 520 ₩
Woo-Jin Park 0.4545 %	50,000	0.4545 %	223 935 ₩
Soon-joo Park 0.4452 %	48,970	0.4452 %	219 321 ₩
Seon-yeong Park 0.4452 %	48,970	0.4452 %	219 321 ₩
DFA Australia Ltd. 0.000909 %	100	0.000909 %	448 ₩

Name	Equities	%	Valuation
KOREAN DRUG CO., LTD. 1.95%	214,911	1.95%	962,520 $

KOREAN DRUG Co., Ltd.

69-10 Wonjeok-ro Sindun-myeon

17303, Icheon-si

http://www.nicepharma.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals

	1st Jan change	Capi.
KOREAN DRUG CO., LTD.	-15.74%	47.74M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.91%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.40%	22.34B
SANDOZ GROUP AG	+18.48%	15.25B
CIPLA LIMITED	+16.12%	14B
ZYDUS LIFESCIENCES LIMITED	+45.12%	12.06B
ONO PHARMACEUTICAL CO., LTD.	-9.58%	6.8B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.49B

Generic Pharmaceuticals